Medicinova (MNOV) Cash from Investing Activities (2010 - 2024)
Medicinova's (MNOV) quarterly Cash from Investing Activities came in at $1.0 in Q4 2024, down 95.45% year-on-year from $22.0 in Q1 2024, and down 99.48% on a QoQ basis from $193.0 in Q3 2024.
Medicinova (MNOV) Cash from Investing Activities (2010 - 2024) Analysis & Trends
Medicinova (MNOV) has 13 years of Cash from Investing Activities data on file, last reported at $1.0 in Q4 2024.
- On a quarterly basis, Cash from Investing Activities fell 95.45% year-over-year to $1.0 in Q4 2024; TTM through Dec 2025 was $216.0, a 108.54% increase from a year earlier, with the FY2025 full-year figure at -$2899.0, down 315.93% from the prior year.
- Cash from Investing Activities for Q4 2024 stood at $1.0, down from $193.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for MNOV reached as high as $39.9 million in Q1 2023 and fell as low as -$30.0 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged $821955.8 across 5 years, with a median of -$1892.0 in 2020.
- Across the five-year window, Cash from Investing Activities sank 350.45% in 2020 and jumped 107.03% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$32698.0 in 2020, then surged by 91.01% to -$2938.0 in 2021, then plunged by 1021173.32% to -$30.0 million in 2022, then surged by 100.0% to $22.0 in 2023, then plunged by 95.45% to $1.0 in 2024.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $1.0 in Q4 2024, $193.0 in Q3 2024, and $22.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | Medicinova | 64.76 Mn | 64.76 Mn | 4,754.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 193.00 |
| Sep 30, 2024 | 193.00 |
| Dec 31, 2023 | 22.00 |
| Dec 31, 2023 | 22.00 |
| Sep 30, 2023 | -2,744.00 |
| Sep 30, 2023 | -2,744.00 |
| Jun 30, 2023 | -18,577.00 |
| Jun 30, 2023 | -18,577.00 |
| Mar 31, 2023 | 39.93 Mn |
| Mar 31, 2023 | 39.93 Mn |
| Dec 31, 2022 | -30.01 Mn |
| Dec 31, 2022 | -30.01 Mn |
| Sep 30, 2021 | -2,938.00 |
| Sep 30, 2021 | -2,938.00 |
| Dec 31, 2020 | -32,698.00 |
| Dec 31, 2020 | -32,698.00 |
| Sep 30, 2020 | -1,190.00 |
| Sep 30, 2020 | -1,190.00 |